Technology applicable to a wide range of drug delivery needs

DelSiTech is the leading technology specialist in biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals and viral vectors. We focus on parenteral and local administration of drug products.

Products with high commercial potential – DelSiTech’s own drug product for high unmet clinical and commercial needs.

Innovative delivery technology – Silica-based drug delivery for controlled release of small molecules and bioparmaceuticals.

New nanotech solutions in drug delivery – DelSiTech is a world technology leader in advanced biodegradable silica based controlled release materials.

The natural solution for your drug delivery needs – We help you to get the most out of your innovations.

 Viral Vectors and vaccines

Controlled release of gene therapy vectors and viral vaccines

 Small molecules

The preferred method for controlled delivery of small molecule drugs,
including poorly or highly soluble compounds

Proteins and macromolecules

Controlled release biologicals and complex biomolecules such as RNA, DNA and carbohydrates

Our partners

DelSiTech currently holds technology collaboration and licensing agreements with AstraZenega, Anticancer Bioscience, Bayer Pharma AG, Innovare R&D, Iveric Bio, Optifye Therapeutics, Unitaid, MedImmune and Solani Therapeutics Ltd and evaluation agreements with several pharma, animal health and biotech companies.